The scientist behind the first widely used coronavirus vaccine says the technology behind it will soon be used to fight cancer. Ozlem Tureci, who co-founded the German company BioNTech with her husband, was working on a way to harness the body’s immune system to tackle tumours when they learned last year of an unknown virus … Read more
The scientist behind the first widely used coronavirus vaccine says the technology behind it will soon be used to fight cancer. Ozlem Tureci, who co-founded the German company BioNTech with her husband, was working on a way to harness the body’s immune system to tackle tumours when they learned last year of an unknown virus … Read more
The experts behind the BioNTech coronavirus jab have developed another vaccine which they claim cures multiple sclerosis (MS) in mice. The new MS vaccine works in a similar way to the coronavirus vaccine, manufactured in conjunction with US pharmaceutical giant Pfizer. A piece of genetic material known as mRNA is inserted into a person’s arm … Read more
The vaccine billionaires’ fortune grows: Inventor of Biontech jab adds $4bn to his fortune while his investors make EIGHT BILLION as countries scramble to inoculate populations Ugur Sahin has seen his wealth grow as share prices in German biotech firm soar Investors Thomas and Andreas Strungmann have profited even more as a result Share prices … Read more
Coronavirus vaccine from Pfizer and BioNTech has been approved by regulators for use in the UK and will roll out NEXT WEEK By Dan Sales For Mailonline Published: 07:10 GMT, 2 December 2020 | Updated: 07:20 GMT, 2 December 2020 A Covid-19 vaccine from Pfizer/BioNTech has been approved by the Medicines and Healthcare products Regulatory … Read more
Coronavirus vaccine from Pfizer and BioNTech has been approved by regulators for use in the UK and will roll out NEXT WEEK By Dan Sales For Mailonline Published: 07:10 GMT, 2 December 2020 | Updated: 07:14 GMT, 2 December 2020 A Covid-19 vaccine from Pfizer/BioNTech has been approved by the Medicines and Healthcare products Regulatory … Read more
Britain has signed deals with two foreign pharmaceutical giants for 90million doses of new coronavirus vaccines with the option of buying 40million more, it was revealed today. Agreement has been reached for 30million doses from BioNTech and German firm Pfizer and 60million doses from France’s Valneva. The figure of 90million is in addition to the 100million … Read more